Search - tctmd.com

Presenter: Seung-Jin Oh, Armando Tellez, Maxwell Afari, Gerard Conditt, Jenn McGregor, Yanping Cheng, Geng-Hua Yi, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

News Industry News

Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S.

September 27, 2012

News Industry News

Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter

April 30, 2012

Presentation CTO 2012

Lesion Preparation of the Calcified Left Main: PTCA vs. Scoring Balloons vs Rotational Atherectomy (with Case Vignettes)

Presenter: Jeffrey Moses

February 23, 2012

Presentation TCT 2012

Very Late Hazard with Primary Stenting versus Primary PTCA for STEMI: A 16 Year Single Center Experience

Presenter: Bruce R. Brodie, Yashashwi Pokharel, Ankit Garg, Charles Hansen, Sally Milks, Michael Cooper, Christopher McAlhany, Thomas Stuckey

January 03, 2012

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

Mental Outlook Linked to Long-term Survival After CHD Hospitalization

Caitlin E. Cox

March 01, 2011

News Daily News

Report on Device Recalls Criticizes Current FDA Approval Process

L.A. McKeown

February 14, 2011

Advertisement

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

Cardiovascular Systems Enrolls First Patient in Coast Study

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

InspireMD Announces Positive Results from iMOS Prime Registry for the MGuard Prime EPS

Los Dispositivos Cardiovasculares son la Clase Más Amplia de Dispositivo Retirados por la FDA desde 2005

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

From the Earliest Balloon PTCA Days: Birth of a Subspecialty (Anecdotes and Lessons)

TriReme Receives Shonin Approval to Market Glider™ PTCA Catheter

ARTHESYS receives CE mark for its 4th generation MAYA PTCA catheter

Study Suggests FFR Diagnostic ‘Gray Zone’ Complicates Clinical Decision Making

Estudio sugiere que ‘zona gris’ en el diagnóstico de la FFR complica la toma de decisiones clínicas

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S.

Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter

Lesion Preparation of the Calcified Left Main: PTCA vs. Scoring Balloons vs Rotational Atherectomy (with Case Vignettes)

Very Late Hazard with Primary Stenting versus Primary PTCA for STEMI: A 16 Year Single Center Experience

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Mental Outlook Linked to Long-term Survival After CHD Hospitalization

Report on Device Recalls Criticizes Current FDA Approval Process

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content